SCHEMBL3517596

SCHEMBL3517596

Cc1ccc(S(=O)(=O)[O-])cc1.O=c1ccc2c([S+](c3ccccc3)c3ccccc3)cccc2o1

nearest known ligand 0.38

Known targets — ChEMBL curated mechanism

CHRM1CHRM2CHRM3CHRM4CHRM5SLC6A2dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 3/20 0.38
ALDH1A1 P00352 6/20 0.37
GAA P10253 3/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
PIK3CD O00329 1/20 0.37
PIK3CA P42336 1/20 0.37
PIK3CB P42338 1/20 0.37
PIK3CG P48736 1/20 0.37
KDM4E B2RXH2 5/20 0.36
GLA P06280 2/20 0.36
MAPT P10636 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
KCNA3 P22001 1/20 0.35
PKM P14618 2/20 0.33
TNKS O95271 1/20 0.33
PARP1 P09874 1/20 0.33
MAOB P27338 1/20 0.33
TNKS2 Q9H2K2 1/20 0.33
PARP2 Q9UGN5 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5034672 0.84 CYP2A6 (0.46) CYP2A6ALDH1A1SMN1; SMN2KDM4EGLA
Trifluoromethanesulfonic Acid SCHEMBL3520616 0.83 CYP2A6 (0.37) CYP2A6ALDH1A1SMN1; SMN2KCNA3CA12
SCHEMBL5042430 0.82 MAOA (0.43) ALDH1A1GAASMN1; SMN2PIK3CDPIK3CA
SCHEMBL3517315 0.80 CYP2A6 (0.40) CYP2A6ALDH1A1SMN1; SMN2KDM4EGLA
SCHEMBL3523127 0.79 RXFP1 (0.36) ALDH1A1GAASMN1; SMN2PIK3CDPIK3CA
SCHEMBL3520929 0.79 ALDH1A1 (0.43) ALDH1A1GAASMN1; SMN2KDM4EGLA
SCHEMBL3137506 0.78 HKDC1 (0.41) ALDH1A1GAASMN1; SMN2CA12CA1
SCHEMBL3522616 0.77 KCNA3 (0.33) CYP2A6KCNA3
SCHEMBL3519395 0.77 KDM4E (0.48) ALDH1A1GAAKDM4EGLAMAPT
SCHEMBL3127290 0.75 CA12 (0.40) ALDH1A1GAASMN1; SMN2KDM4ECA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7833691-B2 Heterocycle-bearing onium salts WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2010-11-16 US disclosed
US-20080161520-A1 Heterocycle-bearing onium salts WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2008-07-03 US disclosed
US-7318991-B2 Diphenylsulfonium compounds in which the S atom is additionally attached to a xanthene-9-onyl-2-yl- or coumarin-7-yl- ring; acid generator for a chemically amplified resist; photopolymerization initiator for polymerizing an epoxide or a vinyl ether WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2008-01-15 US disclosed
US-20050233253-A1 Diphenylsulfonium compounds in which the S atom is additionally attached to a xanthene-9-onyl-2-yl- or coumarin-7-yl- ring; acid generator for a chemically amplified resist; photopolymerization initiator for polymerizing an epoxide or a vinyl ether WAKO PURE CHEMICAL INDUSTRIES, LTD (JP) 2005-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050233253-A1 Diphenylsulfonium compounds in which the S atom is additionally attached to a xanthene-9-onyl-2-yl- or coumarin-7-yl- ring; acid generator for a chemically amplified resist; photopolymerization initiator for polymerizing an epoxide or a vinyl ether NOX4, CBR1, CBR3 CYP2A6 617/4885ALDH1A1 1190/4885GAA 1801/4885
US-20080161520-A1 Heterocycle-bearing onium salts MCM5, NIT2, PCNA CYP2A6 4468/4885ALDH1A1 2676/4885GAA 2270/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.